Frontlight ResearchEarly access
Trial site
Onco Card S.R.L.
- 13running trials
- 2closed trials
The trials here
What the 15 trials at this site are about, from their registry records.
- Conditions
- Lung cancer6 trials
- Myeloproliferative neoplasms5 trials
- Diffuse large B-cell lymphoma2 trials
- Multiple myeloma2 trials
- Chronic lymphocytic leukaemia1 trial
- Hodgkin lymphoma1 trial
- Sarcoma1 trial
- Phase
- Phase 313 trials
- Phase 1/21 trial
- Phase 21 trial
- Status
- Recruiting7 trials
- Active, not recruiting5 trials
- Completed2 trials
- Not yet recruiting1 trial
- Lead sponsor
- Merck Sharp & Dohme LLC5 trials
- Celgene1 trial
- Celgene International II S.a.r.l.1 trial
- F. Hoffmann-La Roche AG1 trial
- GlaxoSmithKline1 trial
- and 6 more
Running trials
Recruiting
Recruiting
Active, not recruiting
Recruiting
Adding Navtemadlin to Ruxolitinib for Patients with Myelofibrosis
Recruiting
Recruiting
Recruiting
Recruiting
Active, not recruiting
Active, not recruiting
Recruiting
A Study of Oral Nuvisertib (TP-3654) in Patients With Myelofibrosis
Active, not recruiting
Active, not recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Lung cancer4 recruiting
- Myeloproliferative neoplasms2 recruiting
- Chronic lymphocytic leukaemia1 recruiting
- Diffuse large B-cell lymphoma1 recruiting
- Hodgkin lymphoma1 recruiting
- Multiple myeloma1 recruiting
- Sarcoma1 recruiting
Closed trials
Completed
Completed
Site data: EU CTIS (euclinicaltrials.eu)Updated 14 Nov 2026